FDA.reportPublic FDA data

Application 206681

Type
ANDA
Sponsor
PIRAMAL CRITICAL

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001OXACILLIN SODIUMOXACILLIN SODIUMINJECTABLE;INJECTIONEQ 1GM BASE/VIALNoNo
002OXACILLIN SODIUMOXACILLIN SODIUMINJECTABLE;INJECTIONEQ 2GM BASE/VIALNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
66794-225OxacillinOxacillinPiramal Critical Care IncANDACurrent
66794-225OxacillinOxacillinPiramal Critical Care IncANDACurrent
66794-225OxacillinOxacillinPiramal Critical Care IncANDACurrent
66794-225OxacillinOxacillinPiramal Critical Care IncANDACurrent
66794-225OxacillinOxacillinPiramal Critical Care IncANDACurrent
66794-226OxacillinOxacillinPiramal Critical Care IncANDACurrent
66794-226OxacillinOxacillinPiramal Critical Care IncANDACurrent
66794-226OxacillinOxacillinPiramal Critical Care IncANDACurrent
66794-226OxacillinOxacillinPiramal Critical Care IncANDACurrent
66794-226OxacillinOxacillinPiramal Critical Care IncANDACurrent
70655-099OxacillinOxacillin SodiumRenaissance SSA, LLCANDACurrent
70655-109OxacillinOxacillin SodiumRenaissance SSA, LLCANDACurrent